PipelinePharma Logo

Generics 10

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Darunavir manufacturers

10 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

10 products found

darunavir

Tablets 400mg, 600mg, 800mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13291
This pharmaceutical company is a leading global provider of affordable medications, with a strong focus on API development, formulation development, and CRAMS (contract research and manufacturing services). They have extensive experience in oncology and boast a portfolio exceeding 50 "first-to-file" ANDAs. The company operates across multiple regions, including Asia, Europe, Africa, the Middle East, and North America, with production lines encompassing prescription medications, over-the-counter drugs, and APIs. They hold numerous GMP certifications and product patents, highlighting their commitment to quality and innovation. Key therapy areas include oncology and other complex drug development segments.

darunavir

Tablets for oral solution 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19828

This fully integrated transnational pharmaceutical company focuses on developing high-quality formulations to address unmet medical needs. They boast a strong presence in the Indian market and expanding global reach, offering both branded and generic medications, as well as APIs. Their state-of-the-art WHO-GMP certified production facility in Mehsana is equipped to manufacture a wide range of dosage forms, including tablets, capsules, liquids, creams, ointments, and injectables. The company prioritizes innovation, with a pipeline of new products targeting areas like opioid addiction treatment. Key therapy areas include antibacterials, anti-infectives, anti-diarrheals, pain management, anemia management, and opioid de-addiction. They hold product patents and adhere to stringent regulatory guidelines from authorities like the USFDA, EDQM, MHRA, and MCA. Their products are distributed across various regions, including the EU and North America.

darunavir

Tablets 300 mg, 600 mg, 800 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #32970
This company is a leading manufacturer of pharmaceutical products, specializing in pellets and granules, tablets, capsules, creams, and ointments. They have a strong track record of success, with GMP certifications from the EU, TGA (Australia), ANVISA (Brazil), and other regulatory bodies. Their expertise extends to multiple therapy areas, leveraging their manufacturing capabilities across various dosage forms. The company caters to a global market, exporting to over 47 countries across regions including North America, South America, Asia, and Europe. They are recognized for their commitment to quality, innovation, and technological advancements in manufacturing processes.

Manufacturer usually replies in 30 days

Want to see all 10 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Darunavir drug?

Darunavir is a protease inhibitor; Darunavir is also an antiretroviral medication used to treat and prevent HIV/AIDS. Darunavir can act as a prevention for potential exposure to HIV, such as needlestick injury. Tibotec developed Darunavir. The US approved the medical use of Darunavir in 2006, and the FDA approved Darunavir in 2008 for people not previously treated for HIV. The Darunavir medication is on the WHO’s List of Essential Medicines. Darunavir is also being studied as a possible treatment for SARS-CoV-2, the coronavirus responsible for COVID-19.

Darunavir manufacturers and wholesalers:

One of Darunavir brand name is Prezista in the US. Darunavir is a globally found drug. One of the leading Darunavir manufacturers is Johnson & Johnson. Darunavir suppliers market it in the form of oral film-coated tablets of 75 mg, 150 mg, 300 mg, 400 mg, 600 mg, and 800 mg. Darunavir can also be found in the final dosage form of an oral suspension of 100 mg/1 ml.

Darunavir for sales:

In the US, the Darunavir wholesale cost is more than $200 per month. Under the brand name Prezista, Darunavir costs change depending on the strength of its final dosage form. For an 800 mg tablet, Prezista costs about $61.76. For a 600 mg tablet, it costs from $25.75 to $30.88, for a 400 mg tablet, it costs about $18.74, for a 300 mg tablet about $16.2, for a 150 mg from $4.59 to $7.72, and for a 75 mg tablet, it costs from $2.3 to $3.86. For a 100 mg/ml oral suspension, Prezista costs about $5.17 per ml. In the developing world, Darunavir costs about US$66 per month.
As Darunavir is a globally found drug, on the internet you can encounter fraudulent websites that will want to sell Darunavir with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid the time-consuming sourcing, and you directly find qualified sellers of Darunavir that have been through quality control procedures to assure they were qualified partners. On the online platform, Darunavir is mostly available from the EU, India, Russia, and Argentina. Thanks to the intuitive online marketplace, you will find Darunavir and many other drugs quickly and efficiently. Placing an order or an inquiry has never been easier than with Pipelinepharma. Let us connect you with Darunavir manufacturers wherever they are in the world.

How to use Darunavir drugs?

Darunavir is mostly taken alongside with other drugs, such as Ritonavir. Darunavir helps to treat and prevent HIV infection, but it is not a cure. Darunavir should be taken with food; it increases the absorption.
There are two types of patients in the treatment of HIV: therapy-naive patient and therapy-experienced patient. To treat HIV with Darunavir, if both types of patients have demonstrated no resistance to the substance, an adult should take 800 mg of Darunavir plus 100 mg of Ritonavir once a day. On the contrary, if therapy-experiences patients with at least one Darunavir Resistance-Associated Substitution or with No Baseline Resistance Information, an adult should take 600 mg of Darunavir 600 mg plus 100 mg of Ritonavir 100 mg twice a day. If a patient is pregnant, she should take 600 mg of Darunavir plus 100 mg Ritonavir twice a day.
Taking Darunavir may have some side effects that include blurred vision, dry mouth, flushed or dry skin, fruit-like breath odor, increased hunger.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.